AN ACT TO CREATE THE FETAL AND INFANT MORTALITY REVIEW PANEL TO REVIEW FETAL DEATHS AND DEATHS OF INFANTS UP TO ONE YEAR OF AGE AND ESTABLISH STRATEGIES TO PREVENT INFANT DEATHS; TO PROVIDE THAT THE REVIEW PANEL SHALL BE MULTIDISCIPLINARY AND COMPOSED OF SUCH MEMBERS AS DEEMED APPROPRIATE BY THE STATE DEPARTMENT OF HEALTH; TO REQUIRE THE REVIEW PANEL TO SUBMIT A REPORT ANNUALLY TO THE HOUSE AND SENATE PUBLIC HEALTH COMMITTEES THAT INCLUDE THE NUMBERS, CAUSES AND RELEVANT DEMOGRAPHIC INFORMATION ON INFANT MORTALITY DEATHS IN MISSISSIPPI, AND APPROPRIATE RECOMMENDATIONS TO THE LEGISLATURE ON HOW TO MOST EFFECTIVELY DIRECT STATE RESOURCES TO DECREASE INFANT MORTALITY IN THE STATE; TO REQUIRE THAT DATA SHALL BE PROVIDED TO THE REVIEW PANEL BY THE STATE MEDICAL EXAMINER'S OFFICE, STATE DEPARTMENT OF HEALTH, DEPARTMENT OF HUMAN SERVICES, MEDICAL EXAMINERS, CORONERS, HEALTH CARE PROVIDERS, LAW ENFORCEMENT AGENCIES, AND ANY OTHER AGENCIES OR OFFICIALS HAVING INFORMATION THAT IS NECESSARY FOR THE REVIEW PANEL TO CARRY OUT ITS DUTIES; TO PROVIDE THAT IN THE CASE OF AN INFANT OR CHILD WHO DIES SUDDENLY AND UNEXPECTEDLY, INCLUDING CASES OF SUDDEN INFANT DEATH SYNDROME (SIDS), SUDDEN UNEXPECTED INFANT DEATH (SUID) OR SUDDEN DEATH IN THE YOUNG (SDY), THE REVIEW PANEL SHALL CONDUCT A COMPREHENSIVE REVIEW OF THE INFANT'S OR CHILD'S MEDICAL, PRENATAL, AND, WHERE APPLICABLE, MATERNAL HEALTH RECORDS FOR THE PURPOSE OF IDENTIFYING POTENTIAL CONTRIBUTING FACTORS AND PREVENTABLE CAUSES OF DEATH; TO PROVIDE THAT SUCH REVIEW SHALL BE CONDUCTED IN ACCORDANCE WITH NATIONALLY RECOGNIZED BEST PRACTICES AND SHOULD INCLUDE CONSIDERATION OF THE INFANT'S OR CHILD'S IMMUNIZATION HISTORY AND ANY MEDICAL TREATMENTS OR INTERVENTIONS AS PART OF THE OVERALL MEDICAL CONTEXT, WITHOUT LIMITATION TO A SPECIFIED TIME PERIOD, AS RELEVANT TO THE PANEL'S DETERMINATION OF CONTRIBUTING FACTORS; TO DIRECT THE STATE DEPARTMENT OF HEALTH TO VERIFY THAT CASES OF SUDDEN AND UNEXPECTED DEATH OF AN INFANT OR CHILD WERE REPORTED TO THE SUID AND SDY CASE REGISTRY AND THAT ANY ADVERSE VACCINE REACTIONS WERE REPORTED TO THE VACCINE ADVERSE EVENT REPORTING SYSTEM (VAERS), AND TO REPORT TO THE SUID AND SDY CASE REGISTRY OR TO VAERS ANY SUCH CASES OR ADVERSE VACCINE REACTIONS THAT WERE NOT PREVIOUSLY REPORTED; TO PROVIDE THAT THE REVIEW PANEL'S REPORT AND RECOMMENDATIONS SHALL BE MADE PUBLIC BY THE STATE DEPARTMENT OF HEALTH; TO REQUIRE PHYSICIANS, HOSPITALS AND PHARMACIES TO PROVIDE REASONABLE ACCESS TO THE REVIEW PANEL TO ALL RELEVANT MEDICAL RECORDS ASSOCIATED WITH A CASE UNDER REVIEW BY THE REVIEW PANEL; TO PROVIDE THAT CERTAIN RECORDS MAINTAINED BY THE STATE DEPARTMENT OF HEALTH SHALL BE CONFIDENTIAL AND NOT SUBJECT TO THE PUBLIC RECORDS ACT OR SUBPOENA, DISCOVERY OR INTRODUCTION INTO EVIDENCE; TO AUTHORIZE THE REVIEW PANEL TO INITIATE ENFORCEMENT ACTIONS AGAINST AGENCIES OR OFFICIALS THAT DO NOT PROVIDE INFORMATION TO THE PANEL IN A COMPLETE AND TIMELY MANNER; TO AMEND SECTION 25-41-3, MISSISSIPPI CODE OF 1972, TO CONFORM TO THE PRECEDING PROVISIONS; TO EXEMPT CERTAIN QUALITY ASSURANCE, QUALITY IMPROVEMENT, PERFORMANCE IMPROVEMENT, AND REVIEW RECORDS OF THE STATE DEPARTMENT OF HEALTH FROM THE PUBLIC RECORDS ACT; TO PROVIDE THAT SUCH RECORDS SHALL BE CONFIDENTIAL AND NOT SUBJECT TO DISCLOSURE, SUBPOENA, OR DISCOVERY; TO EXEMPT CERTAIN RADIOLOGICAL HEALTH AND RADIOACTIVE MATERIAL LICENSING INFORMATION FROM THE PUBLIC RECORDS ACT WHEN DISCLOSURE WOULD POSE A RISK TO PUBLIC HEALTH OR SECURITY; TO AMEND SECTION 25-41-7, MISSISSIPPI CODE OF 1972, TO AUTHORIZE THE STATE DEPARTMENT OF HEALTH TO ENTER EXECUTIVE SESSION OR OTHERWISE CONDUCT A CLOSED MEETING DURING MORBIDITY OR MORTALITY REVIEW COMMITTEE WORK MANDATED BY STATUTE OR REGULATION, SUCH AS THE CHILD DEATH REVIEW PANEL, THE MATERNAL MORTALITY REVIEW COMMITTEE, AND THE FETAL AND INFANT MORTALITY REVIEW PANEL; TO CREATE NEW SECTION 25-61-11.3, MISSISSIPPI CODE OF 1972, TO EXEMPT FROM THE MISSISSIPPI PUBLIC RECORDS ACT OF 1983 DOCUMENTS AND RECORDS USED BY THE STATE DEPARTMENT OF HEALTH DURING MORBIDITY OR MORTALITY REVIEW COMMITTEE WORK MANDATED BY STATUTE OR REGULATION, SUCH AS THE CHILD DEATH REVIEW PANEL, THE MATERNAL MORTALITY REVIEW COMMITTEE, AND THE FETAL AND INFANT MORTALITY REVIEW PANEL; AND FOR RELATED PURPOSES.
The establishment of the Fetal and Infant Mortality Review Panel is projected to enhance the state’s public health efforts by systematically collecting data and analyzing infant mortality cases. With annual reports required to be submitted to the House and Senate Public Health Committees, this initiative seeks to provide evidence-based recommendations to direct state resources effectively. The bill emphasizes collaboration among various health-related entities, ensuring that relevant health data are provided to the panel to facilitate informed decision-making in addressing infant health issues.
House Bill 1637 proposes the creation of the Fetal and Infant Mortality Review Panel, tasked with reviewing fetal deaths and the deaths of infants up to one year of age in Mississippi. This multidisciplinary panel, established under the auspices of the State Department of Health, will conduct thorough evaluations of reported cases, focusing particularly on sudden and unexpected deaths, such as Sudden Infant Death Syndrome (SIDS). The legislation aims to develop and implement strategies aimed at reducing infant mortality rates by identifying potential preventable causes of death through comprehensive reviews of medical records.
Generally, the sentiment surrounding HB 1637 appears to be supportive, with recognition of the necessity for focused efforts on reducing infant deaths in Mississippi, a state known for high infant mortality rates. Public health advocates and lawmakers likely view this bill as a proactive measure to develop targeted strategies for improvement. However, some concerns may arise around data confidentiality and the panel's ability to compel compliance from other agencies, which may lead to discussions about the balance between transparency and privacy.
One notable point of contention revolves around the bill's provisions for confidentiality and the power granted to the review panel. The legislation stipulates that records and deliberations conducted by the panel will remain confidential and not subject to the Mississippi Public Records Act, which raises questions about accountability and public access to information. Another potential issue is the enforcement mechanism allowing the panel to initiate actions against non-compliant entities, which could be perceived as overreach by some stakeholders concerned with regulatory barriers or bureaucratic processes.